<DOC>
	<DOCNO>NCT01225445</DOCNO>
	<brief_summary>Immunoglobulin A ( IgA ) nephropathy common type primary glomerulonephritis world . The treatment IgA nephropathy normal renal function minimal proteinuria unknown . Since angiotensin-converting enzyme ( ACE ) inhibitor reduce proteinuria retard rate decline renal function chronic proteinuric nephropathy , include IgA nephropathy . The investigator conduct randomize control study evaluate efficacy ACE inhibitor treatment early IgA nephropathy . Sixty patient biopsy-proven IgA nephropathy minimal proteinuria recruit . They randomize ramipril 5 year treatment . Blood pressure , proteinuria renal function monitor . This study explore effect ACE inhibitor treatment early IgA nephropathy , major cause dialysis-dependent renal failure .</brief_summary>
	<brief_title>Treatment Early Immunoglobulin A Nephropathy Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Glomerulonephritis , IGA</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<mesh_term>Enzyme Inhibitors</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulin A</mesh_term>
	<criteria>age 18 65 biopsyconfirmed IgA nephropathy proteinuria le 0.5 g per day , normal blood pressure , serum creatinine 120 umol/l willingness give write informed consent willingness participate comply study protocol expect survival less 2 year pregnant nursing mother , woman childbearing potential without effective method birth control history myocardial infarction , congestive heart failure , medical indication necessitate use ACE inhibitor evidence clinically significant hepatic , gastrointestinal , autoimmune disease history malignancy , drug alcohol abuse participation previous trial ACE inhibitor take investigational drug within past 30 day history noncompliance medical regimen patient consider potentially unreliable know history sensitivity / allergy ACE inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>April 2002</verification_date>
</DOC>